Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
91.70
-0.90 (-0.97%)
Sep 3, 2026, 3:19 PM AST

Nahdi Medical Company Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
788.08830.74820.72892.62887.81812.53
Depreciation & Amortization
781.48763.17675.92594.95575.75550.48
Other Amortization
32.0131.5327.5223.1320.8921.02
Loss (Gain) From Sale of Assets
-0.7-0.49-1.54-0.2217.42-0.03
Asset Writedown & Restructuring Costs
---1.6-0.5-10.11-19.49
Provision & Write-off of Bad Debts
3.252.69-0.19-4.493.195.87
Other Operating Activities
60.5531.04-18.16-46.46120.43-23.01
Change in Accounts Receivable
-36.52-128.6237.54-38.166.89-47.65
Change in Inventory
-373.17-628.34-333.74-214.62-127.0185.85
Change in Accounts Payable
111.13170.05338.32257.14153.1743.74
Change in Other Net Operating Assets
173.2861.95-53.44-147.3719.44-95.34
Operating Cash Flow
1,5341,1341,4911,3161,6681,334
Operating Cash Flow Growth
4.89%-23.98%13.32%-21.09%25.03%-15.88%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-358.87-387.09-339.53-353.86-250.27-282.57
Sale of Property, Plant & Equipment
0.70.491.570.250.17.1
Sale (Purchase) of Intangibles
-29.22-30.53-44.97-30.65-24.97-23.89
Investment in Securities
-276.84-----
Other Investing Activities
63.2962.854.9252.7--
Investing Cash Flow
-600.94-354.33-328.01-331.56-275.13-299.36

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--453.96-401.96-435.67-416.96-382.07
Lease Payments
-468.47-453.96-401.96-435.67-416.96-382.07
Total Debt Repaid
-468.47-453.96-401.96-435.67-416.96-382.07
Net Debt Issued (Repaid)
-468.47-453.96-401.96-435.67-416.96-382.07
Common Dividends Paid
-728-728-715-715-300.3-1,260
Financing Cash Flow
-1,196-1,182-1,117-1,151-717.26-1,642

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.030.190.77-0.45-0.21-0.02
Net Cash Flow
-263.19-402.3747.15-166.65675.27-607.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,175746.641,152962.171,4181,051
Free Cash Flow Growth
5.49%-35.18%19.71%-32.13%34.83%-18.50%
Free Cash Flow Margin
11.17%7.31%12.19%11.04%16.45%13.04%
Free Cash Flow Per Share
9.045.748.867.4010.908.09
Levered Free Cash Flow
1,214397.98814.89645.71,040712.08
Unlevered Free Cash Flow
1,269452.98860.96677.231,071761.38
Free Cash Flow After Leases
706.9292.69749.86526.491,001669.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
140.39141.86115.8750.4679.3878.88
Change in Working Capital
-125.29-524.96-11.32-14352.49-13.4